Universal CAR-T Cells Targeting Multiple Myeloma

This study is testing a new type of CAR-T cell therapy (using donor immune cells, not the patient's own) that targets multiple myeloma — a blood cancer — in patients whose disease has returned or not responded to previous treatments. **You may be eligible if:** - You have multiple myeloma that has not achieved complete remission after at least 2 treatment regimens - You have high-risk myeloma and are not eligible for a stem cell transplant due to age or other health issues - You have relapsed after a prior stem cell transplant and have some remaining cancer - You have adequate vein access for the cell collection process **You may NOT be eligible if:** - You are pregnant or nursing - You have an uncontrolled active infection - You have active hepatitis B, hepatitis C, or HIV - You are currently on systemic steroid medications - You have previously received CAR-T cell therapy Talk to your doctor to see if this trial is right for you.